Exane Derivatives’s Cognex CGNX Stock Holding History

Exane Derivatives’s Portfolio CGNX Stock Details CGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$445K	Sell	10,472 -3,423	-25%	-$192K	0.26%	97
2022 Q1	$1.07M	Buy	13,895 +384	+3%	+$26.3K	0.3%	83
2021 Q4	$1.05M	Buy	13,511 +13,508	+450,267%	+$1.09M	0.25%	86
2021 Q3	$241	Hold	3	–	–	﹤0.01%	1001
2021 Q2	$255	Sell	3 -41	-93%	-$3.32K	﹤0.01%	1004
2021 Q1	$3.65K	Hold	44	–	–	﹤0.01%	637
2020 Q4	$3.53K	Hold	44	–	–	﹤0.01%	581
2020 Q3	$2.86K	Hold	44	–	–	﹤0.01%	543
2020 Q2	$2.63K	Hold	44	–	–	﹤0.01%	487
2020 Q1	$1.86K	Hold	44	–	–	﹤0.01%	505
2019 Q4	$2.47K	Hold	44	–	–	﹤0.01%	482
2019 Q3	$2.16K	Hold	44	–	–	﹤0.01%	482
2019 Q2	$2.11K	Hold	44	–	–	﹤0.01%	504
2019 Q1	$2.24K	Sell	44 -60,219	-100%	-$2.88M	﹤0.01%	439
2018 Q4	$2.33M	Buy	60,263 +11,293	+23%	+$490K	0.42%	71
2018 Q3	$2.73M	Buy	48,970 +2,503	+5%	+$128K	0.51%	63
2018 Q2	$2.07M	Buy	+46,467	New	+$2.2M	0.35%	72
2015 Q4	–	Sell	-692	Closed	-$11.9K	–	534
2015 Q3	$11.9K	Sell	692 -3,098	-82%	-$61.5K	﹤0.01%	337
2015 Q2	$91.1K	Buy	3,790 +72	+2%	+$1.77K	0.01%	254
2015 Q1	$92.2K	Buy	+3,718	New	+$79.1K	0.01%	274

Other funds holding CGNX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Exane Derivatives's CGNX Position: Q2 2022 in Review

Exane Derivatives reduced its Cognex (CGNX) stake by 25% in Q2 2022, selling an estimated $192K and leaving 10,472 shares worth $445K. The position accounts for 0.26% of the portfolio, ranked #97.

Exane Derivatives first reported a position in CGNX in Q1 2015 and has held it in 20 quarters since. The position peaked at $2.73M in Q3 2018. 491 funds tracked by Wall St. Rank hold CGNX as of Q2 2022.

Exane Derivatives held 10,472 shares of Cognex worth $445K as of Q2 2022.
Exane Derivatives sold 3,423 Cognex shares in Q2 2022, an estimated $192K.
Cognex made up 0.26% of Exane Derivatives's portfolio in Q2 2022, its #97 holding.
Exane Derivatives first reported a position in Cognex in Q1 2015 and has held it in 20 quarters since.
Exane Derivatives's Cognex position peaked at $2.73M in Q3 2018.
491 funds tracked by Wall St. Rank held Cognex as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.